The cost of Zituvio, also known as omaveloxolone, can vary significantly based on factors such as insurance coverage, pharmacy, and location. As of its approval, Zituvio is a high-cost specialty drug. Patient assistance programs may be available to help eligible individuals reduce out-of-pocket expenses [1].
How much does Zituvio cost without insurance?
Without insurance, the list price for a 30-day supply of Zituvio can be substantial, potentially running into tens of thousands of dollars. Exact figures are not publicly disclosed and fluctuate, but it is priced as a high-cost medication [1].
Are there patient assistance programs for Zituvio?
Yes, manufacturers often offer patient assistance programs for high-cost medications like Zituvio. These programs are typically designed to help uninsured or underinsured patients afford their treatment. Eligibility usually depends on income and insurance status. Information about specific programs and how to apply can often be found on the drug's official website or through healthcare providers [1].
How does Zituvio's price compare to other Friedreich's Ataxia treatments?
Zituvio is one of the first approved treatments specifically for Friedreich's Ataxia (FA). While other treatments for FA may exist for managing symptoms, Zituvio represents a novel therapeutic approach targeting the underlying disease mechanism. Due to its status as a new, specialized therapy, its pricing reflects its development costs and the limited patient population it serves. Comparisons to other FA treatments are challenging as Zituvio targets a specific pathway not addressed by many existing symptom-management approaches [1].
When does Zituvio's patent expire?
Information regarding the specific patent expiry dates for Zituvio is managed by patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on when patents are expected to expire, potentially opening the door for generic or biosimilar competition in the future [2].